ClinicalTrials.gg
CompletedNCT03693079Updated Oct 2, 2018

Investigation of Wet Cupping Therapy on Heavy Metal Levels of Steel Industry Workers

An interventional study of Wet cupping therapy in Heavy Metal Toxicity, sponsored by Karabuk University. Completed at 1 site in Turkey. Open to male participants aged 18 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-10-02.

Sponsored by Karabuk University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 1 year after the study started (first participant enrolled Sep 2017, registered Sep 2018).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
44
Allocation
Not applicable
Ages
18 Years to 55 Years
Sex
Male
01

Study summary

This interventional study investigates the efficacy of Wet cupping therapy on heavy metal levels.The levels of the selected heavy metals will be measured in the blood samples obtained from the participants before and after the interventions

Read the detailed description

Wet cupping therapy (WCT) is a traditional therapy which was used for centuries especially for detoxifiying purposes.Current literature also points out its blood clarifiying capacity in order to illuminate the underlying mechanism of this ancient treatment.

Steel industry workers, different from the general population are exposed to heavy metals more often.Conducting a study in this special group where we will evaluate the levels of selected heavy metals in blood before and after the three sessions of WCT might let us know its detoxifiying capacity based on measurable parameters.

02

Conditions studied

  • Heavy Metal Toxicity

Keywords

  • heavy metal
  • wet cupping therapy
  • steel industry worker
03

In context

Lead sponsor

Karabuk University is the lead sponsor of 143 studies on the registry; 39 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 55 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Healthy individuals
  • Iron and Steel industry workers

Exclusion criteria

Exclusion Criteria:

  • having any chronic disorder
  • being on daily medication
  • wet cupping application in the last 6 months
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
44 participants (actual)

Study arms

  • Experimental
    Wet Cupping

    wet cupping therapy will be applied to all participants

    Procedure: Wet cupping therapy

Interventions

  • ProcedureWet cupping therapy

    CT was applied using plastic disposable vacuum cups on the back in the 5 areas of C7 cervical spine (DU14 acupoint), T2-4 lateral spine bilaterally (BL41-42 acupoint) and T6-8 lateral spine bilaterally (BL44-46). The cupping technique procedure was conducted in five phases: 1. Primary suction; cups are left attached to the skin for 5 minutes. 2. Area disinfection; areas are wiped with sterile gauze after disinfection with povidone iodine. 3. Scarification; Superficial incisions (20-30 gauge), 5 mm length and 1-2 mm depth, are made on the skin with a sterile, number 11 surgical blade. 4. Bloodletting and secondary suction; the cups which had been previously removed are placed again on the scarified areas Blood leaks from the capillary vessels of the skin and subcutaneous tissue and fills the cups, which are left in place for 15 minutes. 5. Removing and dressing; the cups full of blood are removed. The areas of application are wiped with sterile gauze and then a dressing is applied

06

What researchers measure

Primary outcomes

  1. Levels of the selected heavy metals in venous blood samples before and after the interventions

    the levels of the calculated heavy metals will be in ppm

    Time frame: 3 months

Secondary outcomes

  1. Levels of the selected heavy metals in cupping blood samples obtained during the first intervention

    the levels of the calculated heavy metals will be in ppm

    Time frame: 1 month

07

Study locations

1 site
  • Suleyman Ersoy
    Safranbolu, Karabuk 78070, Turkey
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Sep 2017 to primary completion in Aug 2018, 10 months.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 30, 2018
First posted
Oct 2, 2018
StartActual
Sep 3, 2017
Primary completionActual
Aug 1, 2018
CompletionActual
Oct 1, 2018
Last update
Oct 2, 2018
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Oct 2, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03693079
Lead sponsor
Karabuk University
Responsible party
SULEYMAN ERSOY (Assist.Prof. Department of Family Medicine, Karabuk University) — Principal investigator
First posted
Oct 2, 2018
Start date
Sep 3, 2017
Primary completion
Aug 1, 2018
Completion
Oct 1, 2018
Last update
Oct 2, 2018

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion